Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
Information source: Wyeth
Information obtained from ClinicalTrials.gov on August 03, 2007
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Ankylosing Spondylitis
Status: Recruiting
Sponsored by: Wyeth Official(s) and/or principal investigator(s):
Medical Monitor, Study Director, Affiliation: Wyeth Research
Trial Manager, Principal Investigator, Affiliation: MedinfoDEU@wyeth.com
Overall contact:
Trial Manager, Email: clintrialparticipation@wyeth.com
Summary
The purpose of this study is to investigate the incidence of adverse events for patients with AS treated with Enbrel in usual care settings.
Clinical Details
Official title:
Observational Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
Study design: Observational, Natural History, Cross-Sectional, Defined Population, Prospective Study
Eligibility
Minimum age: 18 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Diagnosis of ankylosing spondylitis
Exclusion Criteria:
- Contraindications according SmPC
Locations and Contacts
Trial Manager, Email: clintrialparticipation@wyeth.com
Berlin 10719, Germany; Recruiting
Additional Information
Starting date:
May 2004
Last updated: May 22, 2007
|
